Crossmark Global Holdings Inc. bought a new position in shares of Aetna Inc. (NYSE:AET) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 40,871 shares of the company’s stock, valued at approximately $6,499,000.
Several other institutional investors have also modified their holdings of the stock. Guardian Life Insurance Co. of America raised its holdings in shares of Aetna by 0.7% during the first quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock worth $173,000 after purchasing an additional 9 shares during the last quarter. Financial Architects Inc raised its holdings in shares of Aetna by 1.8% during the second quarter. Financial Architects Inc now owns 1,746 shares of the company’s stock worth $265,000 after purchasing an additional 31 shares during the last quarter. Wedbush Securities Inc. raised its holdings in shares of Aetna by 1.4% during the second quarter. Wedbush Securities Inc. now owns 3,779 shares of the company’s stock worth $574,000 after purchasing an additional 52 shares during the last quarter. Calamos Wealth Management LLC raised its holdings in shares of Aetna by 0.7% during the second quarter. Calamos Wealth Management LLC now owns 8,919 shares of the company’s stock worth $1,354,000 after purchasing an additional 65 shares during the last quarter. Finally, HM Payson & Co. raised its holdings in shares of Aetna by 0.5% during the first quarter. HM Payson & Co. now owns 12,861 shares of the company’s stock worth $1,641,000 after purchasing an additional 69 shares during the last quarter. 89.45% of the stock is owned by hedge funds and other institutional investors.
Shares of Aetna Inc. (NYSE:AET) opened at 170.03 on Wednesday. The stock has a 50 day moving average of $159.75 and a 200 day moving average of $152.04. The firm has a market cap of $56.47 billion, a price-to-earnings ratio of 37.74 and a beta of 0.53. Aetna Inc. has a 12 month low of $104.59 and a 12 month high of $184.98.
Aetna (NYSE:AET) last posted its quarterly earnings results on Tuesday, October 31st. The company reported $2.45 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.07 by $0.38. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The business had revenue of $14.99 billion for the quarter, compared to analysts’ expectations of $15.12 billion. During the same period in the prior year, the company posted $2.07 EPS. The business’s revenue for the quarter was down 5.0% on a year-over-year basis. On average, equities research analysts expect that Aetna Inc. will post $9.50 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Friday, October 27th. Stockholders of record on Thursday, October 12th were paid a dividend of $0.50 per share. The ex-dividend date of this dividend was Wednesday, October 11th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.18%. Aetna’s dividend payout ratio (DPR) is presently 43.67%.
Several brokerages recently issued reports on AET. Cantor Fitzgerald cut shares of Aetna from an “overweight” rating to a “neutral” rating in a report on Thursday, October 26th. BMO Capital Markets raised their target price on shares of Aetna from $175.00 to $200.00 and gave the stock a “market perform” rating in a report on Friday, October 27th. Argus reissued a “buy” rating and set a $185.00 target price (up previously from $165.00) on shares of Aetna in a report on Tuesday, September 12th. Zacks Investment Research cut shares of Aetna from a “buy” rating to a “hold” rating in a report on Tuesday, October 24th. Finally, Royal Bank Of Canada raised their target price on shares of Aetna from $162.00 to $171.00 and gave the stock an “outperform” rating in a report on Friday, August 4th. Nine research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company. Aetna has an average rating of “Buy” and a consensus target price of $163.67.
In other news, EVP Margaret M. Mccarthy sold 10,288 shares of the company’s stock in a transaction on Friday, September 15th. The shares were sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the transaction, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at approximately $5,465,734.55. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, President Karen S. Lynch sold 15,271 shares of the company’s stock in a transaction on Monday, September 18th. The stock was sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the transaction, the president now directly owns 64,261 shares in the company, valued at $10,404,498.51. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.
TRADEMARK VIOLATION WARNING: “40,871 Shares in Aetna Inc. (AET) Acquired by Crossmark Global Holdings Inc.” was first published by Community Financial News and is the property of of Community Financial News. If you are accessing this article on another domain, it was illegally copied and republished in violation of United States & international copyright and trademark legislation. The correct version of this article can be read at https://www.com-unik.info/2017/11/01/40871-shares-in-aetna-inc-aet-acquired-by-crossmark-global-holdings-inc.html.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
What are top analysts saying about Aetna Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Aetna Inc. and related companies.